Trial Profile
Safety and efficacy trial of Ethinylestradiol/drospirenone for contraception in women with benign gynecologic tumor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 19 Dec 2015 New trial record